{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:14:30Z","timestamp":1789913670779,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.vaccine.2011.02.096","type":"journal-article","created":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T08:28:21Z","timestamp":1300264101000},"page":"3531-3537","source":"Crossref","is-referenced-by-count":137,"title":["A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis"],"prefix":"10.1016","volume":"29","author":[{"given":"Jaya","family":"Chakravarty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subodh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay K.","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anup","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill A.","family":"Ashman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa M.","family":"Laughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhea N.","family":"Coler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart J.","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Marie","family":"Beckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen D.","family":"Cowgill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco M.","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.02.096_bib0005","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.pt.2006.09.004","article-title":"Leishmaniasis and poverty","volume":"22","author":"Alvar","year":"2006","journal-title":"Trends Parasitol."},{"issue":"March\u2013April (2)","key":"10.1016\/j.vaccine.2011.02.096_bib0010","first-page":"62","article-title":"Epidemiology of visceral leishmaniasis in India","volume":"12","author":"Bora","year":"1999","journal-title":"Natl. Med. J. India"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2011.02.096_bib0015","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp Immunol Micro Inf Dis"},{"issue":"July (suppl 2)","key":"10.1016\/j.vaccine.2011.02.096_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-3156.2010.02564.x","article-title":"The burden of visceral leishmaniasis in South Asia","volume":"15","author":"Meheus","year":"2010","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.vaccine.2011.02.096_bib0025","series-title":"Hunter's tropical medicine and emerging tropical diseases","first-page":"665","author":"Magill","year":"2000"},{"issue":"5","key":"10.1016\/j.vaccine.2011.02.096_bib0030","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2174\/092986709787458489","article-title":"Leishmaniasis: current treatment and prospects for new drugs and vaccines","volume":"16","author":"Kedzierski","year":"2009","journal-title":"Curr. Med. Chem."},{"issue":"November (11)","key":"10.1016\/j.vaccine.2011.02.096_bib0035","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1111\/j.1365-3156.2006.01732.x","article-title":"Costs of patient management of visceral leishmaniasis in Muzaffarpur, Bihar, India","volume":"11","author":"Meheus","year":"2006","journal-title":"Trop. Med. Int. Health"},{"issue":"July (suppl 2)","key":"10.1016\/j.vaccine.2011.02.096_bib0040","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-3156.2010.02516.x","article-title":"The economic impact of visceral leishmaniasis on rural households in one endemic district of Bihar, India","volume":"15","author":"Sarnoff","year":"2010","journal-title":"Trop. Med. Int. Health"},{"issue":"July (suppl 2)","key":"10.1016\/j.vaccine.2011.02.096_bib0045","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-3156.2010.02520.x","article-title":"Household cost-of-illness of visceral leishmaniasis in Bihar, India","volume":"15","author":"Sundar","year":"2010","journal-title":"Trop. Med. Int. Health"},{"issue":"July (suppl 2)","key":"10.1016\/j.vaccine.2011.02.096_bib0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-3156.2010.02562.x","article-title":"Management of visceral leishmaniasis in rural primary health care services in Bihar, India","volume":"15","author":"Hasker","year":"2010","journal-title":"Trop. Med. Int. Health"},{"issue":"December (11)","key":"10.1016\/j.vaccine.2011.02.096_bib0055","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.4049\/jimmunol.157.11.5034","article-title":"Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis","volume":"157","author":"Webb","year":"1996","journal-title":"J. Immunol."},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.02.096_bib0060","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1128\/IAI.66.7.3279-3289.1998","article-title":"Human and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multicopy gene family","volume":"66","author":"Webb","year":"1998","journal-title":"Infect. Immun."},{"issue":"September (27\u201328)","key":"10.1016\/j.vaccine.2011.02.096_bib0065","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1016\/S0264-410X(02)00302-X","article-title":"Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL adjuvant","volume":"20","author":"Skeiky","year":"2002","journal-title":"Vaccine"},{"issue":"October (20)","key":"10.1016\/j.vaccine.2011.02.096_bib0070","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1007\/s00018-008-8228-6","article-title":"Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant","volume":"65","author":"Casella","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"issue":"Suppl 10","key":"10.1016\/j.vaccine.2011.02.096_bib0075","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/S0966-842X(02)02426-5","article-title":"Taking toll: lipid A mimetics as adjuvants and immunomodulators","volume":"10","author":"Persing","year":"2002","journal-title":"Trends Microbiol."},{"issue":"April (2)","key":"10.1016\/j.vaccine.2011.02.096_bib0080","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1586\/14760584.2.2.239","article-title":"Development of a leishmaniasis vaccine: the importance of MPL","volume":"2","author":"Reed","year":"2003","journal-title":"Expert Rev Vaccines"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2011.02.096_bib0085","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/IAI.70.8.4215-4225.2002","article-title":"Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant. Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis","volume":"70","author":"Coler","year":"2002","journal-title":"Infect. Immun."},{"issue":"December (2)","key":"10.1016\/j.vaccine.2011.02.096_bib0090","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.vaccine.2009.10.045","article-title":"Safety and immunogenicity of a defined vaccine for the prevention of cutaneous leishmaniasis","volume":"28","author":"Velez","year":"2009","journal-title":"Vaccine"},{"issue":"September (40)","key":"10.1016\/j.vaccine.2011.02.096_bib0095","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1016\/j.vaccine.2010.07.063","article-title":"A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis","volume":"28","author":"Nascimento","year":"2010","journal-title":"Vaccine"},{"issue":"October (46)","key":"10.1016\/j.vaccine.2011.02.096_bib0100","doi-asserted-by":"crossref","first-page":"7427","DOI":"10.1016\/j.vaccine.2010.08.092","article-title":"A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with sodium stibogluconate for the treatment of mucosal leishmaniasis","volume":"28","author":"Llanos-Cuentas","year":"2010","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2011.02.096_bib0105","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1073\/pnas.90.2.775","article-title":"Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis","volume":"90","author":"Burns","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2011.02.096_bib0110","unstructured":"ICSSC. Monitoring and Reporting Adverse Events: Appendix VII www Resource Links. 2003 [updated February 6, 2003; cited 2009 April 6]; Available from: http:\/\/www.icssc.org\/Documents\/Resources\/AEManual2003AppendicesFebruary_06_2003%20final.pdf."},{"key":"10.1016\/j.vaccine.2011.02.096_bib0115","series-title":"Human Th1\/Th2 cytokine kit instruction manual","author":"BD Cytometric Bead Array (CBA)","year":"2007"},{"issue":"July (suppl 2)","key":"10.1016\/j.vaccine.2011.02.096_bib0120","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-3156.2010.02519.x","article-title":"The epidemiology of Leishmania donovani infection in high transmission foci in India","volume":"15","author":"Singh","year":"2010","journal-title":"Trop. Med. Int. Health"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.02.096_bib0125","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1111\/j.1365-3156.2006.01735.x","article-title":"Visceral leishmaniasis in southeastern Nepal: a cross-sectional survey on Leishmania donovani infection and its risk factors","volume":"11","author":"Schenkel","year":"2006","journal-title":"Trop. Med. Int. Health"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.02.096_bib0130","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4269\/ajtmh.2009.80.345","article-title":"Longitudinal seroepidemiologic study of visceral leishmaniasis in hyperendemic regions of Bihar, India","volume":"80","author":"Gidwani","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.02.096_bib0135","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3201\/eid1105.040718","article-title":"Risk factors for kala-azar in Bangladesh","volume":"11","author":"Bern","year":"2005","journal-title":"Emerg. Infect. Dis."},{"issue":"November","key":"10.1016\/j.vaccine.2011.02.096_bib0140","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/0035-9203(61)90078-5","article-title":"Immunity in kala-azar","volume":"55","author":"Manson-Bahr","year":"1961","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"November 9241","key":"10.1016\/j.vaccine.2011.02.096_bib0145","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(00)03128-7","article-title":"Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan","volume":"356","author":"Khalil","year":"2000","journal-title":"Lancet"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.02.096_bib0150","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1371\/journal.pmed.0020211","article-title":"Visceral leishmaniasis: new health tools are needed","volume":"2","author":"Hailu","year":"2005","journal-title":"PLoS Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11003446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11003446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T19:31:01Z","timestamp":1685993461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11003446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":30,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0264410X11003446"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.02.096","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}